[1]. Tkach, M. and C. Thery, Communication by Extracellular Vesicles: Where We Are and Where We Need to Go. Cell, 2016. 164(6): p. 1226-1232.
[2]. Thery, C., L. Zitvogel, and S. Amigorena, Exosomes: Composition, biogenesis and function. Nature Reviews Immunology, 2002. 2(8): p. 569-579.
[3]. Pegtel, D.M. and S.J. Gould, Exosomes. Annu Rev Biochem, 2019. 88: p. 487-514.
[4]. Valadi, H., K. Ekstrom, A. Bossios, et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 2007. 9(6): p. 654-U72.
[5]. Meckes, D.G., K.H.Y. Shair, A.R. Marquitz, et al., Human tumor virus utilizes exosomes for intercellular communication. Proceedings of the National Academy of Sciences of the United States of America, 2010. 107(47): p. 20370-20375.
[6]. He, C., S. Zheng, Y. Luo, et al., Exosome Theranostics: Biology and Translational Medicine. Theranostics, 2018. 8(1): p. 237-255.
[7]. Colombo, M., G. Raposo, and C. Thery, Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annual Review of Cell and Developmental Biology, Vol 30, 2014. 30: p. 255-289.
[8]. Thery, C., S. Amigorena, G. Raposo, et al., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol, 2006. Chapter 3: p. Unit 3 22.
[9]. Bartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004. 116(2): p. 281-297.
[10]. Turchinovich, A., L. Weiz, A. Langheinz, et al., Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011. 39(16): p. 7223-33.
[11]. Zhang, J., J. Ma, K. Long, et al., Overexpression of Exosomal Cardioprotective miRNAs Mitigates Hypoxia-Induced H9c2 Cells Apoptosis. Int J Mol Sci, 2017. 18(4).
[12]. Grimolizzi, F., F. Monaco, F. Leoni, et al., Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression. Scientific Reports, 2017. 7.
[13]. Lugli, G., A.M. Cohen, D.A. Bennett, et al., Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. Plos One, 2015. 10(10).
[14]. Mitchell, P.S., R.K. Parkin, E.M. Kroh, et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 2008. 105(30): p. 10513-10518.
[15]. Umezu, T., K. Ohyashiki, M. Kuroda, et al., Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene, 2013. 32(22): p. 2747-2755.
[16]. Alvarez, M.L., M. Khosroheidari, R.K. Ravi, et al., Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney International, 2012. 82(9): p. 1024-1032.
[17]. Shao, Y.K., Y.W. Shen, T. Chen, et al., The functions and clinical applications of tumor-derived exosomes. Oncotarget, 2016. 7(37): p. 60736-60751.
[18]. Ong, S.G., W.H. Lee, M. Huang, et al., Cross Talk of Combined Gene and Cell Therapy in Ischemic Heart Disease Role of Exosomal MicroRNA Transfer. Circulation, 2014. 130(11): p. S60-+.
[19]. Melo, S.A., H. Sugimoto, J.T. O'Connell, et al., Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis. Cancer Cell, 2014. 26(5): p. 707-721.
[20]. Zhou, W.Y., M.Y. Fong, Y.F. Min, et al., Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis. Cancer Cell, 2014. 25(4): p. 501-515.
[21]. Cheng, G.F., Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy. Advanced Drug Delivery Reviews, 2015. 81: p. 75-93.
[22]. He, Y.Q., J.J. Lin, D.L. Kong, et al., Current State of Circulating MicroRNAs as Cancer Biomarkers. Clinical Chemistry, 2015. 61(9): p. 1138-1155.
[23]. Huang, X.Y., T.Z. Yuan, M.H. Liang, et al., Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer. European Urology, 2015. 67(1): p. 33-41.
[24]. Thery, C., K.W. Witwer, E. Aikawa, et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 2018. 7(1): p. 1535750.
[25]. Rekker, K., M. Saare, A.M. Roost, et al., Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem, 2014. 47(1-2): p. 135-8.
[26]. Turchinovich, A. and B. Burwinkel, Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol, 2012. 9(8): p. 1066-75.
[27]. Quackenbush, J.F., P.B. Cassidy, L.M. Pfeffer, et al., Isolation of circulating microRNAs from microvesicles found in human plasma. Methods Mol Biol, 2014. 1102: p. 641-53.
[28]. Muller, L., C.S. Hong, D.B. Stolz, et al., Isolation of biologically-active exosomes from human plasma. J Immunol Methods, 2014. 411: p. 55-65.
[29]. Haney, M.J., N.L. Klyachko, Y.L. Zhaoa, et al., Exosomes as drug delivery vehicles for Parkinson's disease therapy. Journal of Controlled Release, 2015. 207: p. 18-30.
[30]. Ma, J.W., Y. Zhang, K. Tang, et al., Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Research, 2016. 26(6): p. 713-727.